CA4236943060
© Newsfile
19.05.2022
HEM
LISTED
TSX
Hemostemix Announces Financing
News Preview
Calgary, Alberta--(Newsfile Corp. - May 19, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce a non-brokered private placement of up to 15 Million Units priced in the context of the market. Each Unit consists of one common share in the capital of the Company ("Common Share") and one common s...
Themefolio
Profiler
Peergroup
© Newsfile
19.05.2022
HEM
LISTED
TSX
Hemostemix Announces Pete Pavlin, P.Eng., Vice-President Operations
News Preview
Calgary, Alberta--(Newsfile Corp. - May 19, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the appointment of Mr. Peter Pavlin, P.Eng. to the position of Vice President Operations.Mr. Pavlin earned his Bachelor of Applied Science and Master of Engineering degree...
Themefolio
Profiler
Peergroup
© Newsfile
16.05.2022
HEM
LISTED
TSX
Hemostemix Announces Rick Groome as Special Advisor to The CEO
News Preview
Calgary, Alberta--(Newsfile Corp. - May 16, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce Mr. Richard ("Rick") Groome has joined Hemostemix as a special advisor to the CEO, focused on completing a series of financing transactions. Over the last three decades Mr. Groome was...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Newsfile
25.04.2022
HEM
LISTED
TSX
Hemostemix Announces Closing of $2,750,000
News Preview
Calgary, Alberta--(Newsfile Corp. - April 25, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce that it has closed its previously announced $2,750,000 non-brokered secured convertible debenture unit offering (the "Debenture Offering"), pursuant to which the Company issued 2,750 deb...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
23.03.2022
HEM
LISTED
TSX
Hemostemix Announces Settlement Agreement
News Preview
Calgary, Alberta--(Newsfile Corp. - March 23, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it has entered into a settlement agreement (the "Settlement Agreement") with Aspire Health Science, LLC ("Aspire"), and certain other persons, to settle all pending litigation...
Themefolio
Profiler
Peergroup
© Newsfile
03.03.2022
HEM
LISTED
TSX
Hemostemix: Interest Payment on Convertible Debenture
News Preview
Calgary, Alberta--(Newsfile Corp. - March 3, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it will pay interest of $84,804.40 by issuing 446,339 Common Shares, using the March 2, 2022 closing price of $0.19 per share, to the convertible debenture holder in satisfaction of...
Themefolio
Profiler
Peergroup
© Newsfile
02.03.2022
HEM
LISTED
TSX
Hemostemix Announces $2,750,000 Convertible Debenture
News Preview
Calgary, Alberta--(Newsfile Corp. - March 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it has signed a binding term sheet for a private placement of convertible debentures in the amount of $2,549,000, and is offering the same terms to accredited investors who are...
Themefolio
Profiler
Peergroup
© Newsfile
01.03.2022
HEM
LISTED
TSX
Hemostemix Announces Stock Options Grant
News Preview
Calgary, Alberta--(Newsfile Corp. - March 1, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce that in accordance with its stock option plan, it has granted on February 28, 2022, subject to regulatory approval, a total of 1,494,269 stock options to purchase common shares of ...
Themefolio
Profiler
Peergroup
© Newsfile
01.03.2022
HEM
LISTED
TSX
Hemostemix Announces Closing of UNIT Private Placement
News Preview
Calgary, Alberta--(Newsfile Corp. - February 28, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") announces that it has closed its previously announced non-brokered private placement of units ("Units") announced on February 2, 2022, for gross proceeds of $1,204,849.92 (the "Offering"). The Offering consisted of th...
Themefolio
Profiler
Peergroup
© Newsfile
14.02.2022
HEM
LISTED
TSX
Your Fountain of Youth Trademarked by Hemostemix
News Preview
Calgary, Alberta--(Newsfile Corp. - February 14, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce "Your Fountain of Youth" has been trademarked by the Company's intellectual property holding company, Kwalata Trading Limited. Hemostemix has been granted International Trademark Regi...
Themefolio
Profiler
Peergroup
© Newsfile
02.02.2022
HEM
LISTED
TSX
Hemostemix Announces Financing
News Preview
Calgary, Alberta--(Newsfile Corp. - February 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce a non-brokered private placement of up to 7,200,000 Units at $0.14 each for gross proceeds of up to $1,008,000 (the "Offering"). The Offering will consist of the issuance of an aggregate of up to...
Themefolio
Profiler
Peergroup
© Newsfile
21.01.2022
HEM
LISTED
TSX
Hemostemix Partners with My Next Health, Obtains USD $150,000 Subscription at CAD $0.25 Per Unit, and Incorporates Functional Genomics
News Preview
Calgary, Alberta--(Newsfile Corp. - January 21, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce it has signed a Global Master Services Agreement with My Next Health ("MNH"), and has, subject to TSXV approval, obtained a subscription from My Next Health in the amount of USD $...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
11.01.2022
HEM
LISTED
TSX
Hemostemix to Combine ACP-01 with Dr. James Shapiro's Islet Cells to Treat Type 1 Diabetes
News Preview
Calgary, Alberta--(Newsfile Corp. - January 11, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce it has signed a contract with Dr. James Shapiro, University of Alberta, Edmonton and will complete a transfer ACP-01 to Dr. Shapiro's laboratory. The combination of ACP-01, an autologo...
Themefolio
Profiler
Peergroup
© Newsfile
09.12.2021
HEM
LISTED
TSX
Hemostemix Announces Soft Lock of Database as Source Document Verification Completed
News Preview
Calgary, Alberta--(Newsfile Corp. - December 9, 2021) - Hemostemix Inc. (TSXV: HEM) (OTCQB :HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce the source document verification process has been completed and the Company has soft locked the HS 12-01 database. Next, each of the principal investigators will sign off the source d...
Themefolio
Profiler
Peergroup
© Newsfile
28.10.2021
HEM
LISTED
TSX
Hemostemix Confirms OTCQB Listing
News Preview
Calgary, Alberta--(Newsfile Corp. - October 28, 2021) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce it is now up-listed to trade on the OTCQB under symbol HMTXF. The common shares of Hemostemix will continue to trade on the Frankfurt Stock Exchange under the symbol "2VFO" and trade o...
Themefolio
Profiler
Peergroup
© Newsfile
19.10.2021
HEM
LISTED
TSX
Hemostemix Confirms OTCQB Application is Filed
News Preview
Calgary, Alberta--(Newsfile Corp. - October 19, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce it filed with the compliance department of OTCQB all documentation required to up-list the Company's common shares on the OTCQB. The Company's application is under review. The common sha...
Themefolio
Profiler
Peergroup
© Newsfile
14.10.2021
HEM
LISTED
TSX
Hemostemix Announces Dr. Fraser C. Henderson Sr., MD, as Chief Medical Officer
News Preview
Calgary, Alberta--(Newsfile Corp. - October 14, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce the appointment of Dr. Fraser C. Henderson Sr., MD, as its Chief Medical Officer.Dr. Fraser C. Henderson Sr. is an exceptional neurological surgeon with extensive experience and experti...
Themefolio
Profiler
Peergroup
© Newsfile
04.10.2021
HEM
LISTED
TSX
Hemostemix Announces the Second Stem Cell Recipient Interview: One Week to No Chest Pain
News Preview
Calgary, Alberta--(Newsfile Corp. - October 4, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the second in its series of video interviews with ACP-01 recipients taped during August of 2021. With more than 300 patients treated compassionately with ACP-01 for ischemic cardiomyopathy, dilated c...
Themefolio
Profiler
Peergroup
© Newsfile
21.09.2021
HEM
LISTED
TSX
Hemostemix Announces Closing of First Tranche of Unit Private Placement
News Preview
Calgary, Alberta--(Newsfile Corp. - September 21, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") announces it has closed a first tranche of its previously announced non-brokered private placement of units ("Units") announced on September 8, 2021, for gross proceeds of $373,500 (the "Offering"). The Offering consis...
Themefolio
Profiler
Peergroup
© Newsfile
14.09.2021
HEM
LISTED
TSX
Hemostemix Announces the First of a Series of 2021 Video Interviews with ACP-01 Recipients: What the Successful Compassionate Treatment of Ischemic Cardiomyopathy Looks Like After 13 Years
News Preview
Calgary, Alberta--(Newsfile Corp. - September 14, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the first of a series of video interviews with ACP-01 recipient-patients taped during August of 2021. Treated compassionately with ACP-01 for ischemic cardiomyopathy, dilated cardiomyopathy, chron...
Themefolio
Profiler
Peergroup
© Newsfile
08.09.2021
HEM
LISTED
TSX
Hemostemix Announces Five Million Unit Private Placement
News Preview
Calgary, Alberta--(Newsfile Corp. - September 8, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce a non-brokered private placement for gross proceeds of up to $1,250,000 (the "Offering"). The Offering will consist of the issuance of an aggregate of up to 5,000,000 units ("Units") at a price of...
Themefolio
Profiler
Peergroup
© Newsfile
07.07.2021
HEM
LISTED
TSX
Hemostemix Provides Update of Phase II Clinical Trial, 9th Circuit Court Decision Including Cost Award and its Annual General Meeting Results
News Preview
Calgary, Alberta--(Newsfile Corp. - July 6, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to provide an update on the Phase II Clinical Trial, an update of a decision including a cost award from the Ninth Judicial Circuit Court of Orange County, Florida, and the Annual General...
Themefolio
Profiler
Peergroup
© Newsfile
06.07.2021
HEM
LISTED
TSX
Hemostemix Announces Warrant Repricing and Extension
News Preview
Calgary, Alberta--(Newsfile Corp. - July 5, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce, subject to TSX Venture Exchange Approval, that it has extended for two years and repriced to $0.55 from $1, subject to the accelerator provisions stated below on all repriced...
Themefolio
Profiler
Peergroup
© Newsfile
22.06.2021
HEM
LISTED
TSX
Peter Lacey Increases His Investment in Hemostemix Inc.
News Preview
Calgary, Alberta--(Newsfile Corp. - June 21, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") announced today that, further to its June 11, 2021 news release and pursuant to the closing of the offering of debenture units of the Company ("Debenture Units"), Peter Lacey, a director and Chair o...
Themefolio
Profiler
Peergroup
© Newsfile
11.06.2021
HEM
LISTED
TSX
Hemostemix Announces the Closing of a $2,500,000 Convertible Debenture
News Preview
Calgary, Alberta--(Newsfile Corp. - June 11, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it closed its previously announced $2,500,000 convertible debenture order from a director of the Company for Debenture Units priced at $1,000 per Unit as detail...
Themefolio
Profiler
Peergroup
© Newsfile
31.05.2021
HEM
LISTED
TSX
Hemostemix Announces that, Due to the COVID-19 Pandemic, the Annual and Special Meeting Will Only Be Held via Zoom and Shareholders are Requested to Follow the Meeting Instructions Mailed to the Shareholders of Record
News Preview
Calgary, Alberta--(Newsfile Corp. - May 31, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE:2VF0) ("Hemostemix" or the "Company") reminds shareholders that due to COVID-19, its Annual and Special Meeting will be held by Zoom only.Shareholders are invited to the following scheduled Zoom meeting, per the information circular...
Themefolio
Profiler
Peergroup
© Newsfile
29.05.2021
HEM
LISTED
TSX
Hemostemix Announces the TSX Venture's Preliminary Approval of the Closing of a $2,500,000 Convertible Debenture at $0.40 per Unit and Corporate Update
News Preview
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.Calgary, Alberta--(Newsfile Corp. - May 29, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO.F) ("Hemostemix" or the "Company") is pleased to announce that it has obtained preliminary approval from the TSX Venture Exchange to close a $2...
Themefolio
Profiler
Peergroup
© Newsfile
25.05.2021
HEM
LISTED
TSX
Hemostemix to Present at the Emerging Growth Conference
News Preview
Calgary, Alberta--(Newsfile Corp. - May 25, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VFO.F) ("Hemostemix" or the "Company") is pleased to announce that it will present live at the Emerging Growth Conference on May 26, 2021 from 3:30 - 4:00 ET and it invites shareholders, individual and institutional investors, as w...
Themefolio
Profiler
Peergroup
© Newsfile
11.05.2021
HEM
LISTED
TSX
Hemostemix Announces Closing of Unit Private Placement
News Preview
Calgary, Alberta--(Newsfile Corp. - May 10, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") announces it has closed its previously announced non-brokered private placement of units ("Units") announced on April 9, 2021, for gross proceeds of $440,031.90 (the "Offering"). The Offering consisted of the issuance o...
Themefolio
Profiler
Peergroup
© Newsfile
07.05.2021
HEM
LISTED
TSX
Hemostemix Announces Warrant Repricing and Extension
News Preview
Calgary, Alberta--(Newsfile Corp. - May 6, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it has, subject to TSX Venture Exchange Approval, repriced to $0.55 each, and extended the exercise period for two years, the Warrants expiring May 7, 2020 and May 28, 2020...
Themefolio
Profiler
Peergroup
© Newsfile
01.05.2021
HEM
LISTED
TSX
Hemostemix Provides a Clinical Trial Update and Announces the Release and Filing of 2020 Year-end Audited Financial Statements and Management Discussion and Analysis
News Preview
Calgary, Alberta--(Newsfile Corp. - April 30, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce that, with the last patient follow up completed in April, the Company is now focusing its efforts on completing the key areas of the trial including, but not limited to, dat...
Themefolio
Profiler
Peergroup
© Newsfile
26.04.2021
HEM
LISTED
TSX
Hemostemix Reprices and Amends the Terms of Its Unit Offering and Debenture Offering
News Preview
Calgary, Alberta--(Newsfile Corp. - April 26, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VFO.F) ("Hemostemix" or the "Company") announces that, further to its April 9, 2021 news release announcing its Unit Offering, it has increased the aggregate gross proceeds of its Unit Offering to $1,050,000, reduced the Unit pr...
Themefolio
Profiler
Peergroup
© Newsfile
23.04.2021
HEM
LISTED
TSX
Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up and HMTXF Up-list
News Preview
Calgary, Alberta--(Newsfile Corp. - April 23, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO.F) ("Hemostemix" or the "Company") is pleased to announce the completion of the Phase II Clinical Trial subject follow up, as the 65th (final) subject has completed their last follow-up visit. With subject follow up now completed...
Themefolio
Profiler
Peergroup
© Newsfile
10.04.2021
HEM
LISTED
TSX
Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates
News Preview
Calgary, Alberta--(Newsfile Corp. - April 9, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it has secured a $2,500,000 lead order from a director for Debenture Units, and intends to raise gross proceeds of up to $4,000,000 from the non-brokered Offerings of Uni...
Themefolio
Profiler
Peergroup
© Newsfile
08.04.2021
HEM
LISTED
TSX
Hemostemix Announces It Is Trading on the Frankfurt Stock Exchange and It Has Retained HE Capital Markets Ltd.
News Preview
Calgary, Alberta--(Newsfile Corp. - April 8, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0.F) ("Hemostemix" or the "Company") is pleased to announce it is trading on the Frankfurt Stock Exchange under symbol 2VF0.F and it has engaged HE Capital Markets Ltd. (HE Capital) to design and implement a North American and European multimedia...
Themefolio
Profiler
Peergroup
© Newsfile
18.03.2021
HEM
LISTED
TSX
Hemostemix Announces Clinical Trial Update and Contract with GlobeX Data to Encrypt its Communications with Regulatory Authorities
News Preview
Calgary, Alberta--(Newsfile Corp. - March 18, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce that it has contracted two additional clinical research associates, is completing the remaining data entry and source document verifications, and has subscribed with GlobeX Data Ltd. (OTCQB: SWISF) (C...
Themefolio
Profiler
Peergroup
© Newsfile
11.02.2021
HEM
LISTED
TSX
Hemostemix Announces the Protocol First Contract and Warrant Repricing Approval
News Preview
Calgary, Alberta--(Newsfile Corp. - February 11, 2021) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSXV: HEM; OTC: HMTXF) is pleased to announce it has contracted Protocol First to provide it with source document verification services. Protocol First's P1 Source Upload solution, which runs alongside any EDC system, allows site coordinators t...
Themefolio
Profiler
Peergroup
© Newsfile
28.01.2021
HEM
LISTED
TSX
Hemostemix Announces HS 12 - 01 Clinical Trial Completion of Subjects' Follow-Up Visits at the End of March and Warrants Extended and Repriced
News Preview
Calgary, Alberta--(Newsfile Corp. - January 28, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce that all follow-up visits of the subjects enrolled in the HS 12 -01 clinical trial will be completed by March 31, 2021. A total 65 subjects who were enrolled in the trial, randomized 2:1 to receive...
Themefolio
Profiler
Peergroup
© Newsfile
22.01.2021
HEM
LISTED
TSX
Hemostemix Announces the Bread Contract with the Department of Foreign Affairs, Trade & Development Canada
News Preview
Calgary, Alberta--(Newsfile Corp. - January 22, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXD) ("Hemostemix" or the "Company") is pleased to announce it has signed the Building Relationships Entrepreneurs & Dealmakers (BREAD) contract with the Department of Foreign Affairs, Trade and Development. An initiative to assist high-potential, biote...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
